1
|
Altman NL, Gill EA, Kahwash R, Meyer LK, Wagner JA, Karimpour-Fard A, Berning AA, Minobe WA, Carroll IA, Jonas ER, Slavov D, Emani S, Abraham WT, Gollah AR, Ellis SL, Taylor MR, Graw SL, Mestroni L, McKinsey TA, Buttrick PM, Kao DP, Bristow MR. Heart Rate Reduction Is Associated With Reverse Left Ventricular Remodeling and Mechanism-Specific Molecular Phenotypes in Dilated Cardiomyopathy. Circ Heart Fail 2025; 18:e012484. [PMID: 40052260 PMCID: PMC11995853 DOI: 10.1161/circheartfailure.124.012484] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 09/26/2024] [Accepted: 01/28/2025] [Indexed: 04/16/2025]
Abstract
BACKGROUND Heart rate (HR) affects heart failure outcomes, via uncertain mechanisms that may include left ventricular remodeling. However, in human ventricular myocardium, HR change has not been associated with a particular remodeling molecular phenotype. METHODS Patients with nonischemic dilated cardiomyopathy (N=22) in sinus rhythm and refractory to β-blockade for both HR lowering and reverse remodeling were randomized 2:1 double-blind to the HCN4 (hyperpolarization-activated cyclic nucleotide-gated potassium channel 4) channel inhibitor ivabradine or placebo for 24 weeks treatment while maintaining target doses of β-blockers. Reverse remodeling was measured by left ventricular ejection fraction (LVEF), and myocardial gene expression by sequencing RNA extracted from endomyocardial biopsies. The primary statistical analysis was between HR change categories divided at the median, which resulted in Decreased HR (N=90) and Unchanged HR (N=8) groups. RESULTS Respective HRs at baseline and 24 weeks were as follows: Decreased HR, 82.9±6.8 and 69.7±8.0 beats per minute (P=0.0005) and Unchanged HR, 80.8±5.7 and 79.2±11.6 beats per minute (P=0.58). All completing Decreased HR subjects were treated with ivabradine, whereas in the Unchanged HR group, 3 received ivabradine and 5 placebo. In Decreased HR, LVEF increased from 29.4±8.8% at baseline to 44.2±9.4% at 24 weeks (P=0.0003), compared with respective values of 26.6±11.4% and 29.2±12.0% (P=0.28) in Unchanged HR. HR and LVEF changes were not different from a previously conducted β-blocker nonischemic dilated cardiomyopathy study subdivided into LVEF responders and nonresponders. However, differentially expressed genes (N=151) in the Decreased versus Unchanged HR groups were >99% nonconcordant and therefore individually unique compared with β-blocker HR/LVEF responders versus nonresponders (2 shared differentially expressed genes). Multiple unique differentially expressed genes in Decreased HR including NRG1 upregulation are considered cardioprotective or involved in cardiac development. CONCLUSIONS In patients with nonischemic dilated cardiomyopathy in sinus rhythm, HR lowering per se (1) is associated with substantial left ventricular reverse remodeling; (2) its absence can cause β-blocker reverse remodeling nonresponse; and (3) when from HCN4 channel inhibition, results in a unique molecular phenotype. REGISTRATION URL: https://www.clinicaltrials.gov; Unique identifier: NCT02973594.
Collapse
Affiliation(s)
- Natasha L. Altman
- Division of Cardiology (N.L.A., E.A.G., L.K.M., J.A.W., A.K.-F., W.A.M., I.A.C., E.R.J., D.S., S.L.E., M.R.G.T., S.L.G., L.M., T.A.M., P.M.B., D.P.K., M.R.B.), University of Colorado Anschutz Medical Campus, Aurora
| | - Edward A. Gill
- Division of Cardiology (N.L.A., E.A.G., L.K.M., J.A.W., A.K.-F., W.A.M., I.A.C., E.R.J., D.S., S.L.E., M.R.G.T., S.L.G., L.M., T.A.M., P.M.B., D.P.K., M.R.B.), University of Colorado Anschutz Medical Campus, Aurora
| | - Rami Kahwash
- Division of Cardiology, The Ohio State University Wexner Medical Center, Columbus (R.K., S.E., W.T.A., A.R.G.)
| | - Leslie K. Meyer
- Division of Cardiology (N.L.A., E.A.G., L.K.M., J.A.W., A.K.-F., W.A.M., I.A.C., E.R.J., D.S., S.L.E., M.R.G.T., S.L.G., L.M., T.A.M., P.M.B., D.P.K., M.R.B.), University of Colorado Anschutz Medical Campus, Aurora
| | - Jessica A. Wagner
- Division of Cardiology (N.L.A., E.A.G., L.K.M., J.A.W., A.K.-F., W.A.M., I.A.C., E.R.J., D.S., S.L.E., M.R.G.T., S.L.G., L.M., T.A.M., P.M.B., D.P.K., M.R.B.), University of Colorado Anschutz Medical Campus, Aurora
| | - Anis Karimpour-Fard
- Division of Cardiology (N.L.A., E.A.G., L.K.M., J.A.W., A.K.-F., W.A.M., I.A.C., E.R.J., D.S., S.L.E., M.R.G.T., S.L.G., L.M., T.A.M., P.M.B., D.P.K., M.R.B.), University of Colorado Anschutz Medical Campus, Aurora
| | - Amber A. Berning
- Department of Pathology (A.A.B.), University of Colorado Anschutz Medical Campus, Aurora
| | - Wayne A. Minobe
- Division of Cardiology (N.L.A., E.A.G., L.K.M., J.A.W., A.K.-F., W.A.M., I.A.C., E.R.J., D.S., S.L.E., M.R.G.T., S.L.G., L.M., T.A.M., P.M.B., D.P.K., M.R.B.), University of Colorado Anschutz Medical Campus, Aurora
| | - Ian A. Carroll
- Division of Cardiology (N.L.A., E.A.G., L.K.M., J.A.W., A.K.-F., W.A.M., I.A.C., E.R.J., D.S., S.L.E., M.R.G.T., S.L.G., L.M., T.A.M., P.M.B., D.P.K., M.R.B.), University of Colorado Anschutz Medical Campus, Aurora
- Genvara Biopharma, Westminster, CO (I.A.C., M.R.B.)
| | - Eric R. Jonas
- Division of Cardiology (N.L.A., E.A.G., L.K.M., J.A.W., A.K.-F., W.A.M., I.A.C., E.R.J., D.S., S.L.E., M.R.G.T., S.L.G., L.M., T.A.M., P.M.B., D.P.K., M.R.B.), University of Colorado Anschutz Medical Campus, Aurora
| | - Dobromir Slavov
- Division of Cardiology (N.L.A., E.A.G., L.K.M., J.A.W., A.K.-F., W.A.M., I.A.C., E.R.J., D.S., S.L.E., M.R.G.T., S.L.G., L.M., T.A.M., P.M.B., D.P.K., M.R.B.), University of Colorado Anschutz Medical Campus, Aurora
| | - Sitaramesh Emani
- Division of Cardiology, The Ohio State University Wexner Medical Center, Columbus (R.K., S.E., W.T.A., A.R.G.)
| | - William T. Abraham
- Division of Cardiology, The Ohio State University Wexner Medical Center, Columbus (R.K., S.E., W.T.A., A.R.G.)
| | - Alexa R. Gollah
- Division of Cardiology, The Ohio State University Wexner Medical Center, Columbus (R.K., S.E., W.T.A., A.R.G.)
| | - Samuel L. Ellis
- Division of Cardiology (N.L.A., E.A.G., L.K.M., J.A.W., A.K.-F., W.A.M., I.A.C., E.R.J., D.S., S.L.E., M.R.G.T., S.L.G., L.M., T.A.M., P.M.B., D.P.K., M.R.B.), University of Colorado Anschutz Medical Campus, Aurora
| | - Matthew R.G. Taylor
- Division of Cardiology (N.L.A., E.A.G., L.K.M., J.A.W., A.K.-F., W.A.M., I.A.C., E.R.J., D.S., S.L.E., M.R.G.T., S.L.G., L.M., T.A.M., P.M.B., D.P.K., M.R.B.), University of Colorado Anschutz Medical Campus, Aurora
| | - Sharon L. Graw
- Division of Cardiology (N.L.A., E.A.G., L.K.M., J.A.W., A.K.-F., W.A.M., I.A.C., E.R.J., D.S., S.L.E., M.R.G.T., S.L.G., L.M., T.A.M., P.M.B., D.P.K., M.R.B.), University of Colorado Anschutz Medical Campus, Aurora
| | - Luisa Mestroni
- Division of Cardiology (N.L.A., E.A.G., L.K.M., J.A.W., A.K.-F., W.A.M., I.A.C., E.R.J., D.S., S.L.E., M.R.G.T., S.L.G., L.M., T.A.M., P.M.B., D.P.K., M.R.B.), University of Colorado Anschutz Medical Campus, Aurora
| | - Timothy A. McKinsey
- Division of Cardiology (N.L.A., E.A.G., L.K.M., J.A.W., A.K.-F., W.A.M., I.A.C., E.R.J., D.S., S.L.E., M.R.G.T., S.L.G., L.M., T.A.M., P.M.B., D.P.K., M.R.B.), University of Colorado Anschutz Medical Campus, Aurora
| | - Peter M. Buttrick
- Division of Cardiology (N.L.A., E.A.G., L.K.M., J.A.W., A.K.-F., W.A.M., I.A.C., E.R.J., D.S., S.L.E., M.R.G.T., S.L.G., L.M., T.A.M., P.M.B., D.P.K., M.R.B.), University of Colorado Anschutz Medical Campus, Aurora
| | - David P. Kao
- Division of Cardiology (N.L.A., E.A.G., L.K.M., J.A.W., A.K.-F., W.A.M., I.A.C., E.R.J., D.S., S.L.E., M.R.G.T., S.L.G., L.M., T.A.M., P.M.B., D.P.K., M.R.B.), University of Colorado Anschutz Medical Campus, Aurora
| | - Michael R. Bristow
- Division of Cardiology (N.L.A., E.A.G., L.K.M., J.A.W., A.K.-F., W.A.M., I.A.C., E.R.J., D.S., S.L.E., M.R.G.T., S.L.G., L.M., T.A.M., P.M.B., D.P.K., M.R.B.), University of Colorado Anschutz Medical Campus, Aurora
- Genvara Biopharma, Westminster, CO (I.A.C., M.R.B.)
| |
Collapse
|
2
|
Yang S, Xue J, Li Z, Zhang S, Zhang Z, Huang Z, Yung KKL, Lai KWC. Deep Learning-Based Ion Channel Kinetics Analysis for Automated Patch Clamp Recording. ADVANCED SCIENCE (WEINHEIM, BADEN-WURTTEMBERG, GERMANY) 2025; 12:e2404166. [PMID: 39737527 DOI: 10.1002/advs.202404166] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Subscribe] [Scholar Register] [Received: 04/19/2024] [Revised: 08/07/2024] [Indexed: 01/01/2025]
Abstract
The patch clamp technique is a fundamental tool for investigating ion channel dynamics and electrophysiological properties. This study proposes the first artificial intelligence framework for characterizing multiple ion channel kinetics of whole-cell recordings. The framework integrates machine learning for anomaly detection and deep learning for multi-class classification. The anomaly detection excludes recordings that are incompatible with ion channel behavior. The multi-class classification combined a 1D convolutional neural network, bidirectional long short-term memory, and an attention mechanism to capture the spatiotemporal patterns of the recordings. The framework achieves an accuracy of 97.58% in classifying 124 test datasets into six categories based on ion channel kinetics. The utility of the novel framework is demonstrated in two applications: Alzheimer's disease drug screening and nanomatrix-induced neuronal differentiation. In drug screening, the framework illustrates the inhibitory effects of memantine on endogenous channels, and antagonistic interactions among potassium, magnesium, and calcium ion channels. For nanomatrix-induced differentiation, the classifier indicates the effects of differentiation conditions on sodium and potassium channels associated with action potentials, validating the functional properties of differentiated neurons for Parkinson's disease treatment. The proposed framework is promising for enhancing the efficiency and accuracy of ion channel kinetics analysis in electrophysiological research.
Collapse
Affiliation(s)
- Shengjie Yang
- Department of Biomedical Engineering, City University of Hong Kong, Tat Chee Avenue, Kowloon Tong, Kowloon, Hong Kong SAR, China
| | - Jiaqi Xue
- Department of Biomedical Engineering, City University of Hong Kong, Tat Chee Avenue, Kowloon Tong, Kowloon, Hong Kong SAR, China
| | - Ziqi Li
- Department of Biomedical Engineering, City University of Hong Kong, Tat Chee Avenue, Kowloon Tong, Kowloon, Hong Kong SAR, China
| | - Shiqing Zhang
- JNU-HKUST Joint Laboratory for Neuroscience and Innovative Drug Research, College of Pharmacy, Jinan University, 601 West Huangpu Road, Tianhe, Guangzhou, 510632, China
| | - Zhang Zhang
- School of Public Health, Guangzhou Medical University, Xinzao, Panyu, Guangzhou, 511436, China
| | - Zhifeng Huang
- Department of Chemistry, Chinese University of Hong Kong, Shatin, New Territories, Hong Kong SAR, China
| | - Ken Kin Lam Yung
- Department of Science and Environmental Studies, Education University of Hong Kong, 10 Lo Ping Road, Tai Po, New Territories, Hong Kong SAR, China
| | - King Wai Chiu Lai
- Department of Biomedical Engineering, City University of Hong Kong, Tat Chee Avenue, Kowloon Tong, Kowloon, Hong Kong SAR, China
| |
Collapse
|
3
|
Fan W, Sun X, Yuan R, Hou X, Wan J, Liao B. HCN4 and arrhythmias: Insights into base mutations. MUTATION RESEARCH. REVIEWS IN MUTATION RESEARCH 2025; 795:108534. [PMID: 39922561 DOI: 10.1016/j.mrrev.2025.108534] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Subscribe] [Scholar Register] [Received: 09/21/2024] [Revised: 12/13/2024] [Accepted: 02/03/2025] [Indexed: 02/10/2025]
Abstract
In the human sinoatrial node (SAN), HCN4 is the primary subtype among the four HCN (hyperpolarization activated cyclic nucleotide-gated) family subtypes. A tetramer of HCN subunits forms the ion channel conducting the hyperpolarization-activated "funny" current (If), which plays an important regulatory role in maintaining the pacemaker activity of the SAN. With the advancement of detection technologies over the past 20 years, the relationship between base mutations in the HCN4 gene encoding the HCN4 protein and arrhythmias has been continuously elucidated. The expression and kinetic changes of mutated channels were investigated in COS-7, CHO, HEK-293T cells, and Xenopus oocytes, but their functional changes were not elucidated in human myocardial cells. New genome editing methods, such as Base editor and Prime editor, use components of the CRISPR system and other enzymes to directly install single-gene mutation into cellular DNA without causing double-stranded DNA breaks, which reproduce and correct base mutations. In this review, we summarize all base mutations of the HCN4 gene, discuss the clinical characteristics and function of some base mutations, and combine base editors to explore the establishment of disease models and the potential for future gene correction.
Collapse
Affiliation(s)
- Wei Fan
- Department of Cardiovascular Surgery, The Affiliated Hospital, Southwest Medical University, Metabolic Vascular Diseases Key Laboratory of Sichuan Province, Key Laboratory of Cardiovascular Remodeling and Dysfunction, Luzhou, Sichuan 646000, PR China; Key Laboratory of Medical Electrophysiology, Ministry of Education & Medical Electrophysiological Key Laboratory of Sichuan Province, (Collaborative Innovation Center for Prevention of Cardiovascular Diseases), Institute of Cardiovascular Research, Southwest Medical University, Luzhou, Sichuan 646000, PR China
| | - Xuemei Sun
- Department of Pharmacy, The Affiliated Hospital, Southwest Medical University, 25 Taiping Street, Jiangyang District, Luzhou, Sichuan 646000, PR China
| | - Ruoran Yuan
- Department of Cardiovascular Surgery, The Affiliated Hospital, Southwest Medical University, Metabolic Vascular Diseases Key Laboratory of Sichuan Province, Key Laboratory of Cardiovascular Remodeling and Dysfunction, Luzhou, Sichuan 646000, PR China; Key Laboratory of Medical Electrophysiology, Ministry of Education & Medical Electrophysiological Key Laboratory of Sichuan Province, (Collaborative Innovation Center for Prevention of Cardiovascular Diseases), Institute of Cardiovascular Research, Southwest Medical University, Luzhou, Sichuan 646000, PR China
| | - Xiaojie Hou
- Department of Cardiovascular Surgery and Cardiovascular Surgery Research Laboratory, West China Hospital, Sichuan University, Chengdu, Sichuan 610041, PR China
| | - Juyi Wan
- Department of Cardiovascular Surgery, The Affiliated Hospital, Southwest Medical University, Metabolic Vascular Diseases Key Laboratory of Sichuan Province, Key Laboratory of Cardiovascular Remodeling and Dysfunction, Luzhou, Sichuan 646000, PR China; Key Laboratory of Medical Electrophysiology, Ministry of Education & Medical Electrophysiological Key Laboratory of Sichuan Province, (Collaborative Innovation Center for Prevention of Cardiovascular Diseases), Institute of Cardiovascular Research, Southwest Medical University, Luzhou, Sichuan 646000, PR China.
| | - Bin Liao
- Department of Cardiovascular Surgery, The Affiliated Hospital, Southwest Medical University, Metabolic Vascular Diseases Key Laboratory of Sichuan Province, Key Laboratory of Cardiovascular Remodeling and Dysfunction, Luzhou, Sichuan 646000, PR China; Key Laboratory of Medical Electrophysiology, Ministry of Education & Medical Electrophysiological Key Laboratory of Sichuan Province, (Collaborative Innovation Center for Prevention of Cardiovascular Diseases), Institute of Cardiovascular Research, Southwest Medical University, Luzhou, Sichuan 646000, PR China.
| |
Collapse
|